期刊文献+

颅磁共振诊断脑梗塞患者的经颅多谱勒改变

CHANGES OF 3D-TCD IN PATIENTS WITH CEREBRAL INFARCTION COMFIRMED BY MRI
下载PDF
导出
摘要 目的 探讨经颅彩色三维多谱勒超声(3D-TCD)观察脑梗塞患者脑动脉血流状态的价值。方法 对139例经头颅磁共振(MRI)检查确诊的脑梗塞患者做3D-TCD检查,观察主要脑动脉的平均峰流速(Vm);脉动指数(PI)和频谱形态,并与61例元脑梗塞者作对比分析。结果 脑梗塞组各脑动脉Vm减低发生率比无脑梗塞组有增加趋势,在大脑中动脉、大脑前动脉、基底动脉显著增加(P<0.05);PI值增高伴谱态异常发生率较无脑梗塞组有增加趋势,在大脑前动脉、椎动脉显著增加(P<0.05)。结论 3D-TCD是观察脑梗塞病人脑动脉血流状态的有价值的检查方法,是筛选缺血性中风高危病人的重要手段。 Objective To investigate the valuation of three - dimensional transcranial color doppler ultrasonography (3D - TCD) on the changes of cerebral blood flow in patients with cerebral infaretion .Methods 3D- TCD was performed in 139 old cerebral infarction patients confirmed by cranial magnetic resonance imaging (MRI) and in 61 without cerebral infarction old subjects. Mean flow velocity(Vm), pulsatility index (PI) and the shape of frequency band of main cerebral arteries were observed and compared between the two groups .Results In cerebral infaretion group, the incidence of Vm decrease of all cerebral arteries was increased, and the incidences of Vm decrease of middle cerebral artery (MCA), anterior cerebral artery (ACA) and basilar artery (BA) were significantly increased in compare with control group, (P < 0.05); the incidence of PI increase and anomaly of shape of frequency band were increased, and ACA and vertebral artery (VA) were significantly increased (P < 0 .05). Conclusions Cerebral infarction patients usually have changes of cerebral blood flow. 3D - TCD is a valuable method of examination.
出处 《老年医学与保健》 CAS 2000年第4期191-193,共3页 Geriatrics & Health Care
关键词 脑梗塞 血流动力学 NMR 成像 彩超 Cerebral infarction MRI Hemodynamics Cerebral arteries 3D - TCD
  • 相关文献

参考文献6

二级参考文献27

  • 1仲肇舒,孔繁荣.老年脑卒中患者颈动脉彩色多普勒超声检查分析[J].中华老年医学杂志,1996,15(2):101-104. 被引量:12
  • 2王新德 丁翟娥.健康人颈动脉系统颅外段动脉硬化的研究[J].中华内科杂志,1987,26:32-35.
  • 3Niederkor K,Myers LG,Numcl B,et al.Tree-dimensional trandcranial Doppler blood flowmapping in patients with cerebrovascular disorders.Stroke,1988.19:1335
  • 41LassenNA.ClinicalNeuropharmacology1990;13(Suppl3)∶S1-S8.
  • 52Bentue-FerrerD.DecombeR,ReymannJ-M.SchatzC.AllainH.ClinicalNeuropharmacology1990;13(Suppl3)∶S9-S25.3HeissW-DStroke1992;23∶1668-1672.
  • 64KitagawaK.MatsumotoM.MatsushitaK.etal.BrainResearch1996;716∶39-46.
  • 75KataokaK.GtafR.RosnerG.HeissW-D.Stroke1987;18∶188-194.
  • 86LassenNA.TheLancet1966;111-1115.
  • 97KatoH.KogureK,NakanoS.BrainResearch1989;479∶366-370.
  • 108KitagawaK.MatsumotoM.TagayaM.etal.BrainResearch1990;528∶21-24.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部